These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1830099)

  • 1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
    J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA; Chou JM; Tang H; Frazer A
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel 5-HT1A receptor antagonist (S)-UH-301 antagonizes 8-OH-DPAT-induced effects on male as well as female rat copulatory behaviour.
    Johansson CE; Meyerson BJ; Hacksell U
    Eur J Pharmacol; 1991 Sep; 202(1):81-7. PubMed ID: 1838499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
    Yu H; Liu Y; Hacksell U; Lewander T
    Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects.
    Björk L; Fredriksson A; Hacksell U; Lewander T
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):141-7. PubMed ID: 1385999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat.
    Björk L; Lindgren S; Hacksell U; Lewander T
    Eur J Pharmacol; 1991 Jul; 199(3):367-70. PubMed ID: 1833212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
    Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
    J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
    Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.